期刊文献+

Identification of Epsin1 as a regulator for hepatic lipid and glucose metabolism

原文传递
导出
摘要 Obesity related non-alcoholic fatty liver disease(NAFLD),which can progress to steatohepatitis and insulin resistance,has become a major chronic liver disease worldwide.1 As an adaptor of clathrin-mediated endocytosis,Epsin1 plays a role in many diseases,including tumors,atherosclerosis and diabetic wound healing.
出处 《Genes & Diseases》 SCIE CSCD 2023年第1期72-75,共4页 基因与疾病(英文)
基金 This study was supported by the National Natural Science Foundation of China(No.31900834) the China's Overseas Expertise Introduction Project for Discipline Innovation("111 Project")(No.D17015).
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部